Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Med Sci Sports Exerc. 2010 Nov;42(11):1995–2005. doi: 10.1249/MSS.0b013e3181e054f0

Table 2.

Accelerometry determined physical activity for bouts ≥3 METs per minute for ≥10 minutes in duration by categories of BMI, sex, race/ethnicity, age, fitness, diabetes treatment, and cardiovascular disease history (mean ± standard deviation).

Variable Categories Bouts per Day Minutes per Bout* METs per Minute* Total MET-minutes*
BMI 25.0 to <27.0 kg/m2 0.79 ± 1.21 (N=46) 20.74 ± 10.29 (N=35) 5.14 ± 1.11 (N=35) 113.9 ± 87.09 (N=35)
27.0 to <30.0 kg/m2 0.72 ± 0.79 (N=235) 22.21 ± 10.81 (N=172) 5.36 ± 1.16 (N=172) 125.3 ± 81.98 (N=172)
30.0 to <35.0 kg/m2 0.65 ± 0.90 (N=719) 21.09 ± 10.06 (N=522) 5.25 ± 1.00 (N=521) 115.1 ± 71.58 (N=521)
35.0 to <40.0 kg/m2 0.59 ± 0.78 (N=619) 18.79 ± 9.05 (N=448) 5.11 ± 1.02 (N=448) 100.0 ± 67.42 (N=448)
≥40 kg/m2 0.52 ± 0.95 (N=525) 17.02 ± 7.51 (N=346) 4.95 ± 0.86 (N=346) 86.46 ± 49.00 (N=346)
p-value 0.0146 <.0001 <.0001 <.0001
Sex Men 0.83 ± 1.00 (N=917) 20.65 ± 10.26 (N=729) 5.17 ± 1.03 (N=728) 111.7 ± 76.35 (N=728)
Women 0.45 ± 0.73 (N=1228) 18.63 ± 8.64 (N=795) 5.13 ± 0.98 (N=795) 99.34 ± 60.38 (N=795)
p-value <.0001 <.0001 0.4246 0.0005
Race/Ethnicity African American/Black 0.45 ± 0.64 (N=401) 17.94 ± 8.71 (N=264) 5.08 ± 0.99 (N=263) 94.77 ± 60.31 (N=263)
White 0.65 ± 0.88 (N=1563) 20.03 ± 9.58 (N=1129) 5.17 ± 1.00 (N=1 129) 107.7 ± 69.04 (N=1 129)
Hispanic 0.74 ± 1.39 (N=107) 18.88 ± 10.11 (N=82) 5.18 ± 1.16 (N=82) 104.9 ± 88.25 (N=82)
Other/Mixed/Missing 0.55 ± 0.87 (N=74) 19.78 ± 9.98 (N=49) 5.14 ± 0.87 (N=49) 104.7 ± 63.75 (N=49)
p-value 0.0002 0.0121 0.6391 0.0557
Age <50 years 0.60 ± 0.94 (N=208) 19.08 ± 8.34 (N=150) 5.23 ± 1.00 (N=150) 104.2 ± 64.58 (N=150)
50 to <60 years 0.60 ± 0.85 (N=964) 19.60 ± 9.82 (N=695) 5.21 ± 1.05 (N=694) 106.9 ± 73.88 (N=694)
60 to <70 years 0.64 ± 0.92 (N=811) 19.77 ± 9.52 (N=574) 5.09 ± 0.96 (N=574) 104.6 ± 65.13 (N=574)
≥70 years 0.52 ± 0.70 (N=162) 19.40 ± 8.91 (N=105) 4.95 ± 0.89 (N=105) 99.40 ± 58.09 (N=105)
p-value 0.4202 0.8766 0.0223 0.7435
Fitness <6 METs 0.44 ± 0.85 (N=645) 16.55 ± 7.51 (N=382) 4.67 ± 0.65 (N=382) 78.73 ± 42.87 (N=382)
6 to <8 METs 0.57 ± 0.73 (N=881) 19.25 ± 8.87 (N=635) 5.16 ± 0.93 (N=635) 102.4 ± 61.02 (N=635)
8 to <10 METs 0.79 ± 1.07 (N=435) 21.44 ± 10.18 (N=347) 5.39 ± 1.05 (N=346) 119.9 ± 72.42 (N=346)
≥10 METs 1.02 ± 0.91 (N=181) 24.29 ± 11.74 (N=160) 5.75 ± 1.34 (N=160) 148.1 ± 102.8 (N=160)
p-value <.0001 <.0001 <.0001 <.0001
Diabetes Medication No Glucose Lowering Medication 0.64 ± 0.89 (N=267) 20.02 ± 9.57 (N=197) 5.19 ± 1.05 (N=197) 108.0 ± 65.55 (N=197)
Glucose Lowering Medication (Not including insulin or thiazolidinedione) 0.61 ± 0.89 (N=967) 19.81 ± 9.60 (N=688) 5.19 ± 0.98 (N=687) 107.4 ± 68.48 (N=687)
Thiazolidinedione 0.59 ± 0.75 (N=482) 19.77 ± 9.58 (N=342) 5.09 ± 1.04 (N=342) 105.1 ± 72.68 (N=342)
Insulin Alone 0.55 ± 0.71 (N=86) 20.13 ± 10.31 (N=56) 5.07 ± 1.02 (N=56) 106.8 ± 70.93 (N=56)
Insulin plus glucose lowering medication (Not including thiazolidinedione) 0.63 ± 0.86 (N=153) 18.28 ± 8.24 (N=1 12) 5.00 ± 0.88 (N=1 12) 93.50 ± 51.54 (N=112)
Insulin plus thiazolidinedione 0.68 ± 1.23 (N=157) 18.28 ± 9.64 (N=111) 5.21 ± 1.03 (N=111) 100.5 ± 79.85 (N=111)
p-value 0.8631 0.3827 0.2949 0.4437
Cardiovascular Disease History No 0.61 ± 0.99 (N=329) 19.11 ± 9.29 (N=226) 5.03 ± 0.98 (N=226) 99.70 ± 67.85 (N=226)
Yes 0.61 ± 0.85 (N=1816) 19.68 ± 9.54 (N=1298) 5.17 ± 1.01 (N=1297) 106.2 ± 68.87 (N=1297)
p-value 0.9854 0.4001 0.0463 0.1903
*

Indicates that data represent participants who reported ≥1 bout during the observation period that met the criteria of ≥3 METs per minute and ≥10 minutes for that bout.